U.S. RESEARCH ROUNDUP-Abbott, Gilead, Roku

Reuters10-10

Oct 10 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Abbott, Gilead and Roku on Thursday.

HIGHLIGHTS

* Abbott : JP Morgan raises target price to $135 from $125

* Gilead : Raymond James raises target price to $95 from $94

* Roku Inc : JP Morgan raises target price to $92 from $90

Following is a summary of research actions on U.S. companies reported by Reuters on Thursday. Stock entries are in alphabetical order.

* 10X Genomics Inc : Leerink Partners cuts target price to $25 from $35

* Abbott : JP Morgan raises target price to $135 from $125

* Accolade Inc : Raymond James cuts target price to $7 from $11

* Clearside Biomedical Inc : Needham raises target price to $6 from $4

* Costco Wholesale Corp : Oppenheimer raises target price to $980 from $955

* Gilead : Raymond James raises target price to $95 from $94

* IBM : RBC raises target price to $250 from $211

* Moody's Corp : RBC raises target price to $535 from $475

* Onemain Holdings Inc : RBC cuts target price to $58 from $60

* Roku Inc : JP Morgan raises target price to $92 from $90

* S&P Global Inc : RBC raises target price to $595 from $552

(Compiled by Bengaluru Newsroom)

((Diaries@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2474078766?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-10 14:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2474078766","market":"us","top_or_hot":-1,"title":"U.S. RESEARCH ROUNDUP-Abbott, Gilead, Roku","media":"Reuters","content":"<html><body><p>Oct 10 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Abbott, Gilead and Roku on Thursday.</p><p>  HIGHLIGHTS       </p><p>                * Abbott   : JP Morgan raises target price to $135 from $125</p><p>                * Gilead   : Raymond James raises target price to $95 from $94</p><p>                * <a href=\"https://laohu8.com/S/ROKU\">Roku Inc</a>   : JP Morgan raises target price to $92 from $90</p><p> Following is a summary of research actions on U.S. companies reported by Reuters on Thursday. Stock entries are in alphabetical order.   </p><p>                * 10X Genomics Inc   : Leerink Partners cuts target price to $25 from $35</p><p>                * Abbott   : JP Morgan raises target price to $135 from $125</p><p>                * Accolade Inc   : Raymond James cuts target price to $7 from $11</p><p>                * Clearside Biomedical Inc   : Needham raises target price to $6 from $4</p><p>                * Costco Wholesale Corp   : Oppenheimer raises target price to $980 from $955</p><p>                * Gilead   : Raymond James raises target price to $95 from $94</p><p>                * <a href=\"https://laohu8.com/S/IBM\">IBM</a>   : RBC raises target price to $250 from $211</p><p>                * Moody's Corp   : RBC raises target price to $535 from $475</p><p>                * Onemain Holdings Inc   : RBC cuts target price to $58 from $60</p><p>                * Roku Inc   : JP Morgan raises target price to $92 from $90</p><p>                * S&amp;P Global Inc   : RBC raises target price to $595 from $552</p><p>(Compiled by Bengaluru Newsroom)</p><p>((Diaries@thomsonreuters.com))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. RESEARCH ROUNDUP-Abbott, Gilead, Roku</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. RESEARCH ROUNDUP-Abbott, Gilead, Roku\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-10 14:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Oct 10 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Abbott, Gilead and Roku on Thursday.  HIGHLIGHTS                 ...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1057294990.SGD","symbol_name":"Blackrock World Healthscience A2 SGD-H","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2474078766","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2474078766","pubTimestamp":1728542386,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Oct 10 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Abbott, Gilead and Roku on Thursday.  HIGHLIGHTS                 ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","LU1162221912.USD":"FRANKLIN INCOME \"A\" (USD) ACC","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","LU1989772923.USD":"CPR Invest - Climate Action A2 Acc USD-H","LU1989764664.SGD":"CPR Invest - Global Disruptive Opportunities A2 Acc SGD-H","LU0321505439.SGD":"Schroder ISF Global Dividend Maximiser A Acc SGD","LU0321505868.SGD":"Schroder ISF Global Dividend Maximiser A Dis SGD","ACCD":"Accolade, Inc.","LU1914381329.SGD":"Allianz Best Styles Global Equity Cl ET Acc H2-SGD","LU1989764748.USD":"东方汇理环球颠覆性机遇A2 Acc","LU0267386448.USD":"FIDELITY FIRST ALL COUNTRY WORLD \"A\" (USD) INC","LU1043141123.HKD":"NINETY ONE GSF GLOBAL FRANCHISE \"A\" (HKD) INC 2","LU0058720904.USD":"联博国际健康护理基金A","LU1989763690.USD":"东方汇理世代食品基金A2 Acc","LU2264538146.SGD":"Fullerton Lux Funds - Global Absolute Alpha A Acc SGD","CLSD":"Clearside Biomedical Inc.","LU1989763427.SGD":"CPR Invest - Food For Generations A2 Acc SGD-H","LU0106831901.USD":"贝莱德世界金融基金A2","TXG":"10x Genomics, Inc.","LU1066051498.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (USD) INC","LU1430594728.SGD":"Eastspring Investments - Global Low Volatility Equity AS SGD","LU0994945656.USD":"NINETY ONE GSF GLOBAL FRANCHISE \"A\" (USD) INC 2","ABT":"雅培","LU0158827948.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"A\" (USD) INC","SG9999018857.SGD":"United Global Quality Growth Fd Cl Acc SGD-H","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","LU0122379950.USD":"贝莱德世界健康科学A2","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC","SGXZ31699556.SGD":"UGDP UNITED GLOBAL QUALITY GROWTH \"C\" (SGDHDG) ACC","ROKU":"Roku Inc","IBM":"IBM","IE00BJJMRZ35.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC","SPGI":"标普全球","GILD":"吉利德科学","LU1571399168.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"IP\" (USD) ACC","BK4566":"资本集团","LU1585245621.USD":"EASTSPRING INV GLOBAL LOW VOLATILITY EQUITY FUND \"A\" (USD) ACC B","BK4082":"医疗保健设备","OMF":"OneMain Holdings, Inc","LU1121112475.USD":"NINETY ONE GSF GLOBAL FRANCHISE \"A\" (USDHDG) ACC","LU2089984988.USD":"MANULIFE GF HEALTHCARE \"AA\" (USD) ACC","MCO":"穆迪","LU1989773731.SGD":"CPR Invest - Education A2 Acc SGD-H","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","COST":"好市多","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","LU0098860793.USD":"FRANKLIN INCOME \"A\" INC","LU1989772840.SGD":"CPR Invest - Climate Action A2 Acc SGD-H","LU0266013472.USD":"AXA WF - Framlington Longevity Economy A Cap USD"},"translate_title":"美国研究综述-雅培、吉利德、Roku","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ABT":1,"ROKU":1,"ACCD":0.9,"TXG":0.9,"SPGI":0.9,"OMF":0.9,"MCO":0.9,"IBM":0.9,"CLSD":0.9,"COST":0.9,"GILD":0.9},"content_text":"Oct 10 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Abbott, Gilead and Roku on Thursday.  HIGHLIGHTS                       * Abbott   : JP Morgan raises target price to $135 from $125                * Gilead   : Raymond James raises target price to $95 from $94                * Roku Inc   : JP Morgan raises target price to $92 from $90 Following is a summary of research actions on U.S. companies reported by Reuters on Thursday. Stock entries are in alphabetical order.                   * 10X Genomics Inc   : Leerink Partners cuts target price to $25 from $35                * Abbott   : JP Morgan raises target price to $135 from $125                * Accolade Inc   : Raymond James cuts target price to $7 from $11                * Clearside Biomedical Inc   : Needham raises target price to $6 from $4                * Costco Wholesale Corp   : Oppenheimer raises target price to $980 from $955                * Gilead   : Raymond James raises target price to $95 from $94                * IBM   : RBC raises target price to $250 from $211                * Moody's Corp   : RBC raises target price to $535 from $475                * Onemain Holdings Inc   : RBC cuts target price to $58 from $60                * Roku Inc   : JP Morgan raises target price to $92 from $90                * S&P Global Inc   : RBC raises target price to $595 from $552(Compiled by Bengaluru Newsroom)((Diaries@thomsonreuters.com))","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2474078766"}